HL Financial Services’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-3,782
Closed -$203K 678
2015
Q4
$203K Sell
3,782
-352
-9% -$19.8K 0.01% 614
2015
Q3
$211K Sell
4,134
-38,810
-90% -$2.09M 0.01% 585
2015
Q2
$2.42M Buy
42,944
+528
+1% +$33.3K 0.06% 186
2015
Q1
$3.04M Buy
42,416
+24,735
+140% +$1.61M 0.08% 159
2014
Q4
$991K Buy
17,681
+10,608
+150% +$554K 0.03% 272
2014
Q3
$348K Buy
7,073
+246
+4% +$12.5K 0.01% 503
2014
Q2
$346K Buy
6,827
+469
+7% +$23.2K 0.01% 515
2014
Q1
$284K Sell
6,358
-7,855
-55% -$353K 0.01% 549
2013
Q4
$669K Sell
14,213
-734
-5% -$37.2K 0.02% 319
2013
Q3
$790K Sell
14,947
-29,421
-66% -$1.43M 0.03% 262
2013
Q2
$2M Buy
+44,368
New +$2.11M 0.07% 164

Other funds holding RMD

HL Financial Services's RMD Position: Q1 2016 in Review

HL Financial Services sold out of ResMed (RMD) in Q1 2016, closing a stake of 3,782 shares — an estimated $203K sold.

HL Financial Services first reported a position in RMD in Q2 2013 and held it in 11 quarters. The position peaked at $3.04M in Q1 2015. 374 funds tracked by Wall St. Rank hold RMD as of Q1 2016.

  • HL Financial Services reported no remaining ResMed position as of Q1 2016 after selling out during the quarter.
  • HL Financial Services sold 3,782 ResMed shares in Q1 2016, an estimated $203K.
  • HL Financial Services first reported a position in ResMed in Q2 2013 and held it in 11 quarters.
  • HL Financial Services's ResMed position peaked at $3.04M in Q1 2015.
  • 374 funds tracked by Wall St. Rank held ResMed as of Q1 2016.

Based on HL Financial Services's 13F filing for Q1 2016, filed 26 Apr 2016.